Conversely, enhanced GJC within tumors or their microenvironment, achieved via the mis-expression of a constitutively permeable junction-forming connexin Cx26 (Levin and Mercola, 1998), increased tumor incidence. This evidence concerns the gene GJB2 and neoplasm.